Chemicalinfo Chemlink Pharm-Chem Net

Brazil is building up to capture a significantly greater portion of the global pharmaceutical market in the near future.....

Bortezomib, a specific and selective inhibitor of the 26S proteasome with antitumor activity against a wide range of malignancies, has been approved for the treatment of relapsed or refractory multiple myeloma and other cancers. Recently, bortezomib ...

5月12号下午，四川汶川县发生7.8级地震，据有关部门初步统计，已经造成近万人死亡，过万人受伤，灾区民众仍等待着我们的救援。危机当前，让我们众志成城，协力救灾，为地震灾区朋友送上祝福与希望。请伸出您无私的援助之手，为灾区的父老乡亲尽自己的绵薄之力！！中国红十字会总会捐款热线电话、捐款方式中国红十字捐款有如下几种途径：邮局汇...

07-Apr-2008 - India's Jubilant Organosys has made good on promises to make acquisitions in the contract research and manufacturing services (CRAMS) sector with a $255m deal to buy Draxis Health of Canada.

An Indian firm has taken over the contract biologics manufacturing business of German corporation Siegfried.

Switzerland's Siegfried Holding says that a significant jump in 2007 net profit, up 54 per cent to CHF 49.7m ($50m), vindicates its decision to refocus on the active pharmaceutical ingredients and generics sector.

FDA makes progress in plans for China presence
The US Food and Drug Administration (FDA) has alerted the media that it has taken a significant step forward in its plans to establish a presence on the ground in China...

Gilead patent case to help Indian firms25 Jan 2008, 0027 hrs IST,Rupali Mukherjee,TNNNEW DELHI: The US Patent & Trademark Office's rejection of four patents held by Gilead Sciences on a key HIV drug Tenofovir, paves the way for a more affordable ...

En Mйxico se usan anabуlicos en forma legal en el 70% del ganado En los ъltimos aсos se ha satanizado el uso de anabуlicos para engordar el ganado por las intoxicaciones generadas por el uso del Clenbuterol (anabуlico que se utiliza en forma ile...

Synta Pharmaceuticals Initiates Second Phase 1 Clinical Trial of STA-9090, A Novel Hsp90 Inhibitor